216 related articles for article (PubMed ID: 33242433)
21. Acinar-Predominant Pattern Correlates With Poorer Prognosis in Invasive Mucinous Adenocarcinoma of the Lung.
Lin G; Li H; Kuang J; Tang K; Guo Y; Han A; Xie C
Am J Clin Pathol; 2018 Mar; 149(5):373-378. PubMed ID: 29538611
[TBL] [Abstract][Full Text] [Related]
22. NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma.
Duruisseaux M; McLeer-Florin A; Antoine M; Alavizadeh S; Poulot V; Lacave R; Rabbe N; Cadranel J; Wislez M
Cancer Med; 2016 Dec; 5(12):3579-3585. PubMed ID: 27770508
[TBL] [Abstract][Full Text] [Related]
23. Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma.
Kishikawa S; Hayashi T; Saito T; Takamochi K; Kohsaka S; Sano K; Sasahara N; Sasa K; Kurihara T; Hara K; Suehara Y; Takahashi F; Suzuki K; Yao T
Mod Pathol; 2021 Apr; 34(4):786-797. PubMed ID: 33024306
[TBL] [Abstract][Full Text] [Related]
24. Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung.
Jang YJ; Hyun DG; Choi CM; Lee DH; Kim SW; Yoon S; Kim WS; Ji W; Lee JC
BMC Cancer; 2021 Jun; 21(1):731. PubMed ID: 34174841
[TBL] [Abstract][Full Text] [Related]
25. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
Dong Y; Zhou L; Zhao D; Li K; Liu Z; Che N; Liu H
Jpn J Clin Oncol; 2020 Jun; 50(6):701-711. PubMed ID: 32083303
[TBL] [Abstract][Full Text] [Related]
26. Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma.
Hayasaka K; Shiono S; Matsumura Y; Yanagawa N; Suzuki H; Abe J; Sagawa M; Sakurada A; Katahira M; Takahashi S; Endoh M; Okada Y
Ann Thorac Surg; 2018 Jun; 105(6):1648-1654. PubMed ID: 29486179
[TBL] [Abstract][Full Text] [Related]
27. Optimal method for measuring invasive size that predicts survival in invasive mucinous adenocarcinoma of the lung.
Oki T; Aokage K; Nomura S; Tane K; Miyoshi T; Shiiya N; Funai K; Tsuboi M; Ishii G
J Cancer Res Clin Oncol; 2020 May; 146(5):1291-1298. PubMed ID: 32088782
[TBL] [Abstract][Full Text] [Related]
28. Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung: Incidence, prognostic impact, and prediction based on clinicoradiologic factors.
Lee MA; Kang J; Lee HY; Kim W; Shon I; Hwang NY; Kim HK; Choi YS; Kim J; Zo JI; Shim YM
Thorac Cancer; 2020 Nov; 11(11):3145-3154. PubMed ID: 32975379
[TBL] [Abstract][Full Text] [Related]
29. Invasive mucinous adenocarcinoma of the lung: clinicopathological features,
Sun X; Zeng B; Tan X; Chen Z; Pan X; Jiang L
Ann Nucl Med; 2023 Mar; 37(3):198-207. PubMed ID: 36538165
[TBL] [Abstract][Full Text] [Related]
30. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1837-45. PubMed ID: 27342421
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
[TBL] [Abstract][Full Text] [Related]
33. GATA6-positive lung adenocarcinomas are associated with invasive mucinous adenocarcinoma morphology, hepatocyte nuclear factor 4α expression, and KRAS mutations.
Nakajima N; Yoshizawa A; Nakajima T; Hirata M; Furuhata A; Sumiyoshi S; Rokutan-Kurata M; Sonobe M; Menju T; Miyamoto E; Chen-Yoshikawa TF; Date H; Haga H
Histopathology; 2018 Jul; 73(1):38-48. PubMed ID: 29469192
[TBL] [Abstract][Full Text] [Related]
34. Survival after curative resection for mucinous adenocarcinoma of the colorectum.
Kanemitsu Y; Kato T; Hirai T; Yasui K; Morimoto T; Shimizu Y; Kodera Y; Yamamura Y
Dis Colon Rectum; 2003 Feb; 46(2):160-7. PubMed ID: 12576888
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma.
Okada F; Takeda M; Fujii T; Uchiyama T; Sasaki S; Matsuoka M; Nitta Y; Terada C; Maebo K; Morita K; Ishida E; Sawabata N; Ohbayashi C
J Clin Pathol; 2024 Jan; 77(2):111-115. PubMed ID: 36456172
[TBL] [Abstract][Full Text] [Related]
36. Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer.
Azari F; Kennedy G; Chang A; Nadeem B; Sullivan N; Marfatia I; Din A; Desphande C; Kucharczuk J; Delikatny EJ; Singhal S
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4406-4418. PubMed ID: 35876868
[TBL] [Abstract][Full Text] [Related]
37. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma.
Mimae T; Tsutani Y; Miyata Y; Yoshiya T; Ibuki Y; Kushitani K; Takeshima Y; Nakayama H; Okumura S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1820-6. PubMed ID: 24507979
[TBL] [Abstract][Full Text] [Related]
38. Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma.
Cai L; Wang J; Yan J; Zeng J; Zhu L; Liang J; Pan C; Huang X; Jin J; Xu Y; Wang F; Shao Y; Xu Q; Xia G; Xing M; Xu X; Jiang Y
Front Oncol; 2020; 10():603671. PubMed ID: 33505917
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with nodal metastasis in 2-centimeter or less non-small cell lung cancer.
Pani E; Kennedy G; Zheng X; Ukert B; Jarrar D; Gaughan C; Pechet T; Kucharczuk J; Singhal S
J Thorac Cardiovasc Surg; 2020 Mar; 159(3):1088-1096.e1. PubMed ID: 31610968
[TBL] [Abstract][Full Text] [Related]
40. The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.
Izar B; Zhou H; Heist RS; Azzoli CG; Muzikansky A; Scribner EE; Bernardo LA; Dias-Santagata D; Iafrate AJ; Lanuti M
J Thorac Oncol; 2014 Sep; 9(9):1363-9. PubMed ID: 25122432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]